Jul. 31 at 9:39 PM
$IXHL $APMD worth pushing towards £1B. and us £35m, when this goes it's going to be massive. The timing could be next week or next decade. That's the issue. I don't think this is going to be a quick rerate as we move through Dreamzz. There's only a small chance of a buyout or major partnership before Q1/Q2 2027. I do think this could potentially drop to
$2.50, but just as likely to hit
$4-5. This is a guessing game and no-one on here knows the outcome. Still bullish on the drugs value going forward, but bullish on the BOD, any more dilution would be a killer. I can't see another reverse split, as the buyback could buyback the whole company before we get anywhere near
$1.
